ΔABP-α2

A putative anti-RBD (SARS-CoV-2 Spike) peptide.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

ΔABP-α2 is a computationally modelled RBD (SARS-CoV-2 Spike) peptide inhibitor (Jaiswal et al., 2021).

Link	Tested on	Impact factor	Notes	Publication date
A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex Spike protein ACE2 Peptide In silico	in silico	3.22	Predicted to bind SARS-CoV-2 Spike protein RBD and thus inhibit the Spike-ACE2 complex formation.	Mar/01/2021

Link	Publication date
A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex	Mar/01/2021